Bruker Corporation revenue for the last year amounted to 2.96 B USD, the most of which — 960.40 M USD — came from its highest performing source at the moment, Bruker Scientific Instruments Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection, the year earlier bringing 822.20 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Bruker Corporation 777.70 M USD, and the year before that — 696.10 M USD.